Literature DB >> 25693305

Evidence-based management of Kawasaki disease in the emergency department.

Kara K Seaton, Anupam Kharbanda.   

Abstract

Kawasaki disease, also known as mucocutaneous lymph node syndrome, was first described in Japan in 1967. It is currently the leading cause of acquired heart disease in children in the United States. Untreated Kawasaki disease may lead to the formation of coronary artery aneurysms and sudden cardiac death in children. This vasculitis presents with fever for ≥ 5 days, plus a combination of key criteria. Because each of the symptoms commonly occurs in other childhood illnesses, the disease can be difficult to diagnose, especially in children who present with an incomplete form of the disease. At this time, the etiology of the disease remains unknown, and there is no single diagnostic test to confirm the diagnosis. This issue reviews the presentation, diagnostic criteria, and management of Kawasaki disease in the emergency department. Emergency clinicians should consider Kawasaki disease as a diagnosis in pediatric patients presenting with prolonged fever, as prompt evaluation and management can significantly decrease the risk of serious cardiac sequelae.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25693305

Source DB:  PubMed          Journal:  Pediatr Emerg Med Pract        ISSN: 1549-9650


  4 in total

1.  Patient ranking with temporally annotated data.

Authors:  Luca Bonomi; Xiaoqian Jiang
Journal:  J Biomed Inform       Date:  2017-12-19       Impact factor: 6.317

2.  Noise-tolerant similarity search in temporal medical data.

Authors:  Luca Bonomi; Liyue Fan; Xiaoqian Jiang
Journal:  J Biomed Inform       Date:  2020-12-25       Impact factor: 6.317

3.  Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.

Authors:  Sang Hoon Lee; Eun Song Song; Somy Yoon; Seunghee Hong; Hwa Jin Cho; Eun Mi Yang; Gwang Hyeon Eom; Gaeun Kang; Young Kuk Cho
Journal:  Dis Markers       Date:  2017-11-22       Impact factor: 3.434

Review 4.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.